The Marshall Protocol Study Site Home
The Marshall Protocol Study Site > PROF. MARSHALL'S PERSPECTIVE > Prof. Marshall's Perspective > Witholding ARBs after surgery increases risk of death

 Moderated by: Prof Trevor Marshall Topic closed
Prof Trevor Marshall
Foundation Staff

Joined: Fri Jul 9th, 2004
Location: Thousand Oaks, California USA
Posts: 16298
Status:  Offline
Science Daily:


"Out of 1,167,482 surgical admissions, 30,173 inpatient surgical admissions met inclusion criteria. Approximately 10,205 patients (33.8%) in the cohort did not resume ARB by day 2. Those that resumed ARB had a 30-day mortality rate of 1.3% (260 of 19,968), whereas 3.2% (323 of 10,205) died in the group that withheld ARB. The unadjusted hazard ratio (HR) for 30-day mortality was 2.45 for those that withheld ARB compared with those that resumed"

A new paper has also come out confirming that Olmesartan actually reduced plaque deposits in the 'MORE' study:


inactive member

Joined: Sun Sep 24th, 2006
Location: Newtownards, N. Ireland, United Kingdom
Posts: 1658
Status:  Offline
This is one of those times I wish this platform had a like button.

* We can help you understand chronic disease, but only your physician is licensed to give you medical care *

Powered by WowBB 1.7 - Entire site Copyright © 2004-2021 Autoimmunity Research Foundation, All Rights Reserved
Click here to view our PRIVACY POLICY
Page processed in 0.0441 seconds (93% database + 7% PHP). 17 queries executed.